Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
2Customers
2Debt Items
0Related Chains
Source-Backed Evidence Depth
Dermata Therapeutics, Inc. (DRMA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
3Distinct source URLs
7High confidence
0.866Average confidence
2026-07-01Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Dermata Therapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
H-C-WAINWRIGHT-CO-LLC
H-C-WAINWRIGHT-CO-LLC
92%
H.C. Wainwright & Co., LLC ("Wainwright") acted as the Company's exclusive placement agent in connection with the Private Placement
REKA-FARM
REKA-FARM
92%
The Company is currently a party to an exclusive Supplier Agreement for the supply of the Spongilla raw material used in the Company's Tome skincare brand.
REKA-FARM-LLC
REKA-FARM-LLC
92%
Reka-Farm will supply us with the Spongilla raw materials necessary for use in the development of our products
Dermata Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
REKA-FARM-LLC
REKA-FARM-LLC
85%
illa in commercial quantities. However, due to our ability to obtain the Spongilla from Reka-Farm, we remain confident that we will not need to incur these costs for the foreseeable future. See “Busi…
CO-LLC
CO-LLC
62%
h our first cosmetic product, the Foundational Treatment, in the middle of 2026. In the future, we plan to offer additional products that target specific needs of consumers. For example, for consumer…
Dermata Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
DRMA-DEBT-9133
Warrants outstanding: 5424598
90%
xbrl warrant detail from xbrl 2026-03-31.
DRMA-DEBT-9134
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2022-12-31.
Dermata Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Dermata Therapeutics, Inc..
Dermata Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
DRMA-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 2 tracked holders.
Dermata Therapeutics, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
